Elizabeth Cohen

Despite having a multibillion-dollar budget, the CDC doesn’t have authority from Congress to hire consultants in a timely way when an urgent situation arises.

Judy Salins considers herself a smart, empowered patient, but until this week, she had no idea that the medicine she takes to defend herself against Covid-19 isn’t protecting her as well as it used to.

Another woman has come forward with the harrowing details of how the Supreme Court’s decision four months ago to overturn Roe v. Wade put her life in danger.

As the US government distributes some of the most significant investments ever to improve public health, grass-roots organizations that work in underserved communities say they’re being overlooked.

Jill Hartle might seem an unlikely advocate for abortion rights, but after a devastating pregnancy loss, she’s raising her voice.

Some vaccine advisers to the federal government say they’re “disappointed” and “angry” that government scientists and the pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.

Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday.

Just when Beth and Kyle Long received the worst news of their life, an Ohio law made their searing pain even worse.

As the US mulls over its future Covid-19 vaccination plan, data from three large health care systems indicate that even though a small percentage of people under age 65 have gotten the new Covid-19 booster, people this age are not becoming severely ill and overwhelming hospitals.

Dino Carlone was frightened when he was diagnosed with bladder cancer three years ago, but his spirits were buoyed when he learned that he could get help from a highly effective drug with a great track record.